Oncology

Advocate’s Children’s Hospitals are members of the Children’s Oncology Group (COG) clinical trials network. COG grew out of several cooperative research groups established by the National Cancer Institute in 1955. COG coordinates cancer clinical trials at 238 member institutions, including cancer centers of all major universities and teaching hospitals. By treating children in clinical trials, COG members have increased the cancer cure rate for children from less than 10 percent in the 1950s to nearly 80 percent at present, in COG member hospitals. Over half of all children in the United States with cancer are enrolled in a clinical trial.

A significant number of clinical trials are open and ongoing at both Advocate Children’s Hospitals to offer children with cancer access to the newest types of treatments and diagnostic methods. We are currently enrolling children in clinical trials with the following types of cancers: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin’s disease, Non-Hodgkins disease, renal (kidney) tumors, Wilm’s tumor, neuroblastoma, lymphoma, rhabdomyosarcoma, Ewing’s sarcoma, hepatoblastoma, brain tumors, and medulloblastoma. If you are interested in additional information on these clinical trials, please contact, for Hope Children’s Hospital, please contact Jane Suszek, Clinical Research Associate, at 708-684-4384, jane.suszek@advocatehealth.com.; for Lutheran General Children’s Hospital, Rina DiMaso, Clinical Research Associate, at 847-723-9472, rina.dimaso@advocatehealth.com

Related links:

• Midwest Children's Brain Tumor Center (at Lutheran General Children's Hospital)
• Children’s Oncology Group
• CureSearch
• American Cancer Society
• Leukemia and Lymphoma Society
• Candlelighters Childhood Cancer Foundation
• National Cancer Institute
• National Children’s Cancer Society